IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC

Medtech

Near-infrared fluorescently-labeled peptide heterodimer contrast agent for cancer imaging in the biliary tract

Grants
$1.0M
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
—
No published records under this name
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantDepartment of Health and Human Services · Phase II · In-vivo study of KSP/QRH heptapeptide dimer for detection of biliary intra-epithelial neoplasia$1,022,055
Federal grant · SBIR/STTR

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1921STEADI SYSTEMS, LLC——
1922Innoventric——
1923RAPHA ROBOTICS INC——
1924IN VIVO MICROSYSTEMS TECHNOLOGIES, LLC——
1925BIOSYNTAGMA, LLC——
1926WEARABLE DEFENSE LLC——
1927SEER, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.